Abstract: The present invention relates to a system for applying and/or spreading a pharmaceutical and/or cosmetic composition on the skin. The system (100) comprises a container (110) for receiving a pharmaceutical and/or cosmetic composition (140); a dosing unit (120) mechanically coupled with the container (100) for dispensing a predetermined amount (141) of the composition (140) from the container (110) through an opening (121) of the dosing unit (120); and an applicator (130). The applicator (130) is configured to be temporarily coated or loaded with the predetermined amount (141) of the composition (140). Moreover, the applicator (130) is configured for spreading the predetermined amount (141) of the composition (140) on a skin area of a user. The applicator (130) is detachably connectable with the container (110) or the dosing unit (120).

Abstract: The present invention relates to an oil-in-water emulsion comprising a glycopyrronium salt and an emulsifier system comprising at least one macrogol glycerol fatty acid ester, at least one glycerol fatty acid ester and at least one fatty alcohol. Moreover, the present invention relates to such an emulsion for use as a medicament, in particular for treating and preventing diseases in conjunction with excessive sweating. In addition the present invention relates to the non-therapeutic use of such an oil-in-water emulsion for topical application on the skin of a mammal in order to reduce sweating.

Abstract: The present invention relates to a topical emulsion comprising at least one anticholinergic compound, an oil phase, a water phase and an emulsifier for use in treating patients suffering from hyperhidrosis rated as 1 or 2, preferably as 2, in the Hyperhidrosis Disease Severity Scale (HDSS). In addition the present invention relates to the non-therapeutic use of such a topical emulsion for reducing sweating in subjects who experience ordinary sweating and/or excessive sweating, wherein the subjects suffer from sweating rated as or 2, preferably as 2, in the Hyperhidrosis Disease Severity Scale (HDSS).

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The present invention relates to pharmaceutical and cosmetic formulations containing an extract of Echinacea and linoleic acid derivatives, particularly emulsions containing an extract of Echinacea and linoleic acid derivatives as an active agent combination, and the use of such formulations as medicines, medicinal products and/or cosmetics.

Abstract: The present invention relates to pharmaceutical and cosmetic formulations containing an extract of Echinacea and linoleic acid derivatives, particularly emulsions containing an extract of Echinacea and linoleic acid derivatives as an active agent combination, and the use of such formulations as medicines, medicinal products and/or cosmetics.

Abstract: The present invention relates to an oil-in-water emulsion comprising a glycopyrronium salt and an emulsifier system comprising at least one macrogol glycerol fatty acid ester, at least one glycerol fatty acid ester and at least one fatty alcohol. Moreover, the present invention relates to such an emulsion for use as a medicament, in particular for treating and preventing diseases in conjunction with excessive sweating. In addition the present invention relates to the non-therapeutic use of such an oil-in-water emulsion for topical application on the skin of a mammal in order to reduce sweating.

Abstract: The invention relates to Lysyl-Prolyl-Threonine lyophilized formulations, in particular to L-Lysyl-D-Prolyl-L-Threonine lyophilized formulations, that are stable in storage, and to a process for preparing the lyophilized formulations. Moreover, the invention relates to pharmaceutical and cosmetic compositions comprising the lyophilized formulations, that are used in the therapeutic and/or prophylactic treatment, diagnosis and/or therapy of pain-related diseases, pruritus-related diseases, inflammatory diseases, and/or other diseases in a mammal.

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The present invention relates to a water-in-oil emulsion and its use as a skin care product, in particular as a cosmetic and as a (dermatologic) medicament for aged skin. The emulsion contains a disperse/internal aqueous phase comprising an ?-hydroxy-C2-C6-carboxylic acid, a continuous/external oil phase and an emulsifier system, comprising polyglyceryl-3-polyricinoleate, sorbitan oleate and sucrose polystearate, wherein the emulsion has a pH of 1 to 5.

Abstract: The use of eprotirome in the prevention and/or treatment of hair disorders is herein disclosed.

Abstract: The invention relates to Lysyl-Prolyl- Threonine lyophilized formulations, in particular to L-Lysyl-D-Prolyl-L-Threonine lyophilized formulations, that are stable in storage, and to a process for preparing the lyophilized formulations. Moreover, the invention relates to pharmaceutical and cosmetic compositions comprising the lyophilized formulations, that are used in the therapeutic and/or prophylactic treatment, diagnosis and/or therapy of pain-related diseases, pruritus-related diseases, inflammatory diseases, and/or other diseases in a mammal.

Abstract: The present invention relates to tripeptide compounds according to the general formula (1) and their use as a medicament, in particular as anti-inflammatory agents.

Abstract: The present invention relates to perhydroquinoxaline compounds according to the general formula (1), their use as a medicament, in particular as analgesic, antipruritic and anti-inflammatory agents, and their preparation.

Abstract: The present invention relates to a novel class of 1,3-benzoxazol-2(3H)-ones and their use as a medicament, preferably as a dermatologic agent, and as a cosmetic. These novel compounds are particularly useful in treating and/or preventing inflammation, irritation, itching, pruritus, pain, oedema and/or pro-allergic or allergic conditions in a patient. Usually they are topically applied to the skin or mucosa in the form of a pharmaceutical or cosmetic composition comprising the compound and a pharmaceutically and/or cosmetically acceptable carrier.

Abstract: The use of eprotirome in the prevention and/or treatment of hair disorders is herein disclosed.

Abstract: The invention relates to amphotheric surfactants for use in preventing and/or treating vaginal infections, in particular for preventing and treating pathogenic vaginal biofilms in vaginal infections, as well as to pharmaceutical compositions containing the amphoteric surfactants as active ingredients.

Abstract: In a device for treating blood vessels with a laser, the laser provides a beam in a wavelength range from 750 to 850 nm, preferably 805 nm. The device has a measuring unit which measures the concentration of a chromophore (preferably indocyanine green) administered to the patient in the patient's blood vessels. The device further comprises a control unit which controls the power of the laser in a contrary sense to the measured concentration.